A new study found that treating patients with a compound derived from cannabis can significantly reduce or eliminate seizures...
GW Pharmaceuticals has announced successful trials of its drug Epidiolex, a cannabidiol-based compound for treating patients...
London, England – The GW Pharmaceuticals (NASDAQ: GWPH) announced Monday a successful Phase 3 trial for the drug Epidiolex....
A new cannabis-based drug developed by GW pharmaceuticals could shed a light of hope for children who suffer from...